NCT00303407

Brief Summary

To determine the efficacy and to measure the complications of prophylactic anticoagulation using low-molecular weight heparin in adult cancer patients under palliative care

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Timeline
Completed

Started Jan 2001

Geographic Reach
1 country

1 active site

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2001

Completed
1.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2002

Completed
3.7 years until next milestone

First Submitted

Initial submission to the registry

March 15, 2006

Completed
1 day until next milestone

First Posted

Study publicly available on registry

March 16, 2006

Completed
Last Updated

March 16, 2006

Status Verified

December 1, 2005

First QC Date

March 15, 2006

Last Update Submit

March 15, 2006

Conditions

CancerVenous Thromboembolism

Interventions

nadroparinDRUG

Eligibility Criteria

Age0 Years+
Sexall
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Cancer patients in palliative care
  • Patients fully informed about their condition
  • Signed informed consent

You may not qualify if:

  • Absence of advanced cancer
  • Cancer previously cured
  • Absence of discerning capacity
  • Active anti-thrombotic treatment with heparins or coumarines
  • Thrombocytopenia \<50G/l
  • PTT \>45sec
  • TP\<35%
  • Active bleeding
  • Renal failure \<20ml/min
  • Past history of heparin-induced thrombocytopenia

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Center of Continuous Care, chemin de la Savonnière

Collonge-Bellerive (Geneva), Canton of Geneva, 1245, Switzerland

Location

Related Publications (1)

  • Prandoni P. Antithrombotic strategies in patients with cancer. Thromb Haemost. 1997 Jul;78(1):141-4.

    PMID: 9198144BACKGROUND

MeSH Terms

Conditions

NeoplasmsVenous Thromboembolism

Interventions

Nadroparin

Condition Hierarchy (Ancestors)

ThromboembolismEmbolism and ThrombosisVascular DiseasesCardiovascular Diseases

Intervention Hierarchy (Ancestors)

Heparin, Low-Molecular-WeightHeparinGlycosaminoglycansPolysaccharidesCarbohydrates

Study Officials

  • Catherine Weber, MD

    Center of Continuous Care, chemin de la Savonnière 11, CH-1245 Collonge-Bellerive

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
DEFINED POPULATION
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER

Study Record Dates

First Submitted

March 15, 2006

First Posted

March 16, 2006

Study Start

January 1, 2001

Study Completion

July 1, 2002

Last Updated

March 16, 2006

Record last verified: 2005-12

Locations

CH(1)